All Type of News
Pharma distribution industry’s signature gathering against the serial number reporting system
The pharmaceutical distribution industry has decided to gather signatures to request reconsideration of the real-time serial number reporting system.
The Korea Pharmaceutical Distribution Association held the 2017 1s...
Enlarged gap among pharma distribution companies in debt ratio
It was evaluated the Korean pharmaceutical distribution companies’ debt ratio was 238.5% last year, decreased by 19.0%p, which showed the better financial soundness than the year before. However, the ratio gap was ext...
Oscotec’s FDA-approved clinical trials for treatment of acute myeloid leukemia
Oscotec(CEO Jung-Geun Kim), a new drug development company, announced on the 13th that it made an agreement since the U.S. Phase 1 clinical trial project of the next-generation new drug candidate(SKI-G-801) for the tr...
MFDS encounters dilemma over implementation of Integrated Narcotics Management
The Ministry of Food and Drug Safety(MFDS) encountered a dilemma over the Integrated Narcotics Management System which was expected to be enforced by states from June.
There is a high chance for the system to fail if...
Legal base to order to revise and add precautions on health functional foods
A bill was proposed at the National Assembly to give an order to revise and add precautions to the manufacturer when a health-related adverse reaction is reported for consuming health functional foods.
People’s Party...
‘Basaglar,’ price-competitive biosimilar, launched in Korea
‘Basaglar,’ the first insulin glargine biosimilar in Korea, will be launched.
Lilly Korea and Boehringer Ingelheim Korea held a meeting to celebrate the launch of ‘Basaglar(generic name: insulin glargine 100U/ml),’ a...
Geo-Young and Baekje Pharmaceuticals recorded sales more than KRW 1 trillion
Following Geo-Young, Baekje Pharmaceuticals exceeded KRW 1 trillion sales, which will encourage enlargement in the pharmaceutical distribution industry.
According to the analysis result of 139 pharmaceutical distribu...
Celltrion applies sales approval of Herzuma to enter Japanese market
Celltrion announced it applied sales approval of Herzuma(CT-P6, generic name: trastuzumab), a self-developed anticancer antibody biosimilar, at the Japanese Ministry of Health, Labour and Welfare on the 11th to enter ...
“Keywords for success of biosimilars are quality differentiation and tailored strategy by country”
Experts evaluated success of biosimilars depends on quality differentiation and tailored strategy by country.
Moreover, it anticipated Europe leads the biosimilar market now, but the U.S. will take the leadership wit...
KPDS, “Novartis’ illegality is clear… it is time to explain generics’ safety to patients”
The Korean Pharmacists for Democratic Society(KPDS) urged prompt and strict administrative measures for the Novartis Korea’s rebate case.
In the statement on the 12th, the KPDS announced the Ministry of Health and We...
